Coya Therapeutics Inc (COYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||
| Net Income | -5,116 | -1,703 | -4,892 |
| Depreciation Amortization | 8 | 4 | 16 |
| Accounts payable and accrued liabilities | 404 | -367 | N/A |
| Other Working Capital | 642 | -307 | 739 |
| Other Operating Activity | 638 | 388 | 234 |
| Operating Cash Flow | $-3,425 | $-1,985 | $-3,903 |
| Cash Flows From Investing Activities | |||
| PPE Investments | N/A | N/A | -137 |
| Investing Cash Flow | $0 | $N/A | $-137 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 10,469 | N/A | N/A |
| Other Financing Activity | -997 | -65 | -341 |
| Financing Cash Flow | $9,472 | $-65 | $-341 |
| Beginning Cash Position | 4,340 | 4,340 | 8,721 |
| End Cash Position | 10,387 | 2,290 | 4,340 |
| Net Cash Flow | $6,047 | $-2,050 | $-4,381 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,425 | -1,985 | -3,903 |
| Free Cash Flow | -3,425 | -1,985 | -3,903 |